S A Shurtleff
Overview
Explore the profile of S A Shurtleff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
1337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaste S, Qi A, Smith K, Surprise H, Lovorn E, Boyett J, et al.
Pediatr Blood Cancer
. 2014 Jan;
61(5):885-93.
PMID: 24395288
Background: We sought to improve lumbar spine bone mineral density (LS-BMD) in long-term survivors of childhood acute lymphoblastic leukemia (ALL) using calcium and cholecalciferol supplementation. Procedure: This double-blind, placebo-controlled trial...
2.
Sandlund J, Shurtleff S, Onciu M, Horwitz E, Leung W, Howard V, et al.
Pediatr Blood Cancer
. 2013 Apr;
60(9):E85-7.
PMID: 23589280
X-linked lymphoproliferative syndrome (XLP) is caused by mutations in SH2D1A, and is associated with overwhelming infectious mononucleosis, aplastic anemia, hypogammaglobulinemia, and B-cell lymphomas. However, the frequency of SH2D1A mutations in...
3.
Andersson A, Miller D, Lynch J, Lemoff A, Cai Z, Pounds S, et al.
Leukemia
. 2011 Jun;
25(10):1570-7.
PMID: 21647154
To investigate the frequency of isocitrate dehydrogenase 1 (IDH1) and 2 (IDH2) mutations in pediatric acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL), we sequenced these genes in diagnostic...
4.
Shurtleff S, Downing J, Morris S
Methods Mol Med
. 2011 Mar;
6:75-89.
PMID: 21380699
The diagnosis and classification of non-Hodgkin's lymphoma (NHL) has traditionally been made based on morphologic and mununophenotypic criteria. Unfortunately, because of the diverse nature of this group of diseases, rehante...
5.
Shurtleff S, Downing J, Morris S
Methods Mol Med
. 2011 Feb;
55:157-76.
PMID: 21312108
The development of modern molecular biology techniques and their use in characterizing the genetic abnormalities that are of pathogenic significance in non-Hodgkin's lymphoma (NHL) now provides a means to diagnose...
6.
Conley M, Farmer D, Dobbs A, Howard V, Aiba Y, Shurtleff S, et al.
Clin Exp Immunol
. 2008 Feb;
152(1):39-44.
PMID: 18241230
Reduced B cell numbers and a mutation in Btk are considered sufficient to make the diagnosis of X-linked agammaglobulinaemia. In the process of conducting family studies, we identified a 58-year-old...
7.
Mullighan C, Kennedy A, Zhou X, Radtke I, Phillips L, Shurtleff S, et al.
Leukemia
. 2007 Jun;
21(9):2000-9.
PMID: 17597811
Somatic mutations in nucleophosmin (NPM1) occur in approximately 35% of adult acute myeloid leukemia (AML). To assess the frequency of NPM1 mutations in pediatric AML, we sequenced NPM1 in the...
8.
Mathew S, Shurtleff S, Raimondi S
Genes Chromosomes Cancer
. 2001 Sep;
32(2):188-93.
PMID: 11550288
In childhood B-lineage acute lymphoblastic leukemia (ALL), the most common genetic change, the ETV6-CBFA2 (TEL-AML1) fusion resulting from the cryptic t(12;21)(p13;q22) is associated with a favorable outcome. Therefore, it is...
9.
Shih L, Fu J, Shurtleff S, Morris S, Downing J
Genes Chromosomes Cancer
. 2001 Mar;
30(4):402-6.
PMID: 11241793
To determine whether the BCL10 mutation plays a role in the oncogenesis of plasma cell dyscrasias, we used polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) and direct sequencing analysis and examined...
10.
Athale U, Shurtleff S, Jenkins J, Poquette C, Tan M, Downing J, et al.
J Pediatr Hematol Oncol
. 2001 Feb;
23(2):99-104.
PMID: 11216714
Purpose: To compare the use of reverse transcriptase polymerase chain reaction (RT-PCR) with that of morphology-based methods for diagnosis, staging, and detection of metastatic disease in pediatric alveolar rhabdomyosarcoma (ARMS),...